Answer
Rinvoq 15 mg prolonged-release tablets containing upadacitinib hemihydrate are purple, 14 × 8 mm, oblong and biconvex, with 'a15' imprinted on one side.
Sources for this answer
- RINVOQ 15 mg prolonged-release tabletsAbbVie Ltd · emc · SmPC §3 Pharmaceutical form · Version 28Document updated
Sources checked